Skip to main content
Clinical Trials/ACTRN12615000346572
ACTRN12615000346572
Recruiting
Not Applicable

Safety and efficacy of fluoroscopic guided modified single needle trans-discal approach for neurolytic retrocrural celiac plexus block in patients with inoperable upper gastrointestinal cancer pain

Tanta University0 sites30 target enrollmentApril 15, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
upper gastrointestinal cancer pain
Sponsor
Tanta University
Enrollment
30
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 15, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\- Thirty patients have inoperable upper gastrointestinal tumors including (cancer lower third esophagus, stomach, pancreas, biliary tract).
  • 2\- With uncontrolled visceral pain (Visual analogue scale greater than or equal to 7/10\).
  • 3\- With maximum tolerable dose of opioids.

Exclusion Criteria

  • 1\-Patients have coagulopathy.
  • 2\- Patients have local infection at the area of needle insertion.
  • 3\- Decompensate cardiac disorders.
  • 4\- Hemodynamic instability.
  • 5\- Radiological evident metastatic lesions.
  • 6\- Psychiatric disorders affecting cooperation.
  • 7\- Has undergone previous blocks affecting severity of the present pain.

Outcomes

Primary Outcomes

Not specified

Similar Trials